Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjunctive therapy for intractable epilepsy with ethotoin.

V Biton1, J R Gates, F J Ritter

  • 1Department of Neurology, University of Minnesota, Minneapolis.

Epilepsia
|July 1, 1990
PubMed
Summary

Ethotoin (EHN) showed initial promise for intractable seizure control, with over 50% of patients experiencing reduced seizure frequency. However, efficacy decreased over time, highlighting the need for further trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Studies on sex pheromone of American cockroach, with emphasis on structure elucidation of periplanone-A.

Journal of chemical ecology·2014
Same author

Evaluation of the FIRI (Fasting Insulin Resistance Index) and selected plasma parameters associated with insulin resistance as predictors of cardiovascular mortality in rural Chinese women.

Asia Pacific journal of clinical nutrition·2014
Same author

Perampanel Study 207: long-term open-label evaluation in patients with epilepsy.

Acta neurologica Scandinavica·2012
Same author

Tolerability and safety of perampanel: two randomized dose-escalation studies.

Acta neurologica Scandinavica·2011
Same author

Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.

Neurology·2006
Same author

Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.

Neurology·2005

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Intractable seizures pose significant treatment challenges.
  • Ethotoin (EHN) is an antiepileptic drug used as adjunctive therapy.

Purpose of the Study:

  • To evaluate the efficacy of ethotoin (EHN) in patients with intractable seizures.
  • To assess the long-term effectiveness of EHN for seizure frequency reduction.

Main Methods:

  • Retrospective review of 46 patients treated with ethotoin (EHN).
  • Analysis of seizure frequency reduction at 1 month and over the last 3 months of follow-up (mean 10.6 months).

Main Results:

  • Approximately 51% of patients achieved >50% reduction in overall seizure frequency at 1 month.
  • This reduction decreased to approximately 25% by the last 3 months of follow-up.

Related Experiment Videos

  • Tonic seizure frequency reduction (>50%) was observed in 60% at 1 month and 35% by the last 3 months.

    • Conclusions:

    • Ethotoin (EHN) demonstrates initial efficacy in reducing seizure frequency, particularly for tonic seizures.
    • Sustained efficacy of EHN appears limited, suggesting potential for treatment tolerance or disease progression.
    • Prospective controlled trials are warranted to confirm EHN's effectiveness, especially for tonic seizures.